Clinical Trial Update: Efficacy, Safety and Pharmacokinetics Study of Antroquinonol to Treat NSCLC [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating antroquinonol for non-small cell lung cancer (Stage IV) has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Antroquinonol (antroquinonol)

Snippet

Sponsor: Golden Biotechnology Corporation | Conditions: Non-small Cell Lung Cancer Stage IV | Phase 2 | Status: COMPLETED | Results posted: 2019-12-26